A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA) — Stella
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
(10 sites) United States
Cedars-Sinai Medical Center, Los Angeles, California University of California Irvine, Orange, California Connie Frank Transplant Center at UCSF, San Francisco, California Yale University of Medicine, New Haven, Connecticut Medstar Georgetown Transplant Institute - 2-PHC, Washington D.C., District of Columbia Comprehensive Transplant Center, Chicago, Illinois John Hopkins Hospital, Baltimore, Maryland University of Minnesota, Minneapolis, Minnesota New York University Langone Health, New York, New York Penn Transplant Institute, Philadelphia, Pennsylvania
Last updated February 2026